Rationally designed antibodies
US7396917B2 · kind B2 · utility
32Cited by
32References
65Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2002 |
| Grant date | Jul 8, 2008 |
| Priority date | — |
| Expiry date | Jan 19, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies or fragments thereof having at least two CDR regions replaced or fused with biologically active peptides are described. Compositions containing such antibodies or fragments thereof are useful in therapeutic and diagnostic modalities.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.